欧洲不孕不育检测市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲不孕不育检测市场 – 行业趋势及 2029 年预测

  • Medical Devices
  • Upcoming Report
  • Jan 2022
  • Europe
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Europe Infertility Testing Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 2.95 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Metropolis Healthcare Limited India
  • CENTOGENE N.V
  • Halotech DNA
  • Procter & Gamble
  • Andrology Solutions SA

>欧洲不孕不育检测市场,按类型(女性不孕不育检测和男性不孕不育检测)、检测试剂盒(人类促卵泡激素 (FSH) 尿液检测试剂盒、促黄体激素 (LH) 尿液检测试剂盒、人绒毛膜促性腺激素 (HCG) 激素血液检测试剂盒等)、处方模式(基于处方和非处方 (OTC))、分销渠道(医院药房、网上药房、药店和药店)、最终用途(生育中心、医院和诊所、研究机构和冷冻库)、国家(德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、欧洲其他地区)、行业趋势和预测到 2029 年。

欧洲不孕不育检测市场

不孕不育检测的市场分析和见解

不孕不育检测市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析该市场在上述预测期内的复合年增长率为 7.05%。

不孕症 检测基本上是一系列检测,用于确定女性无法怀孕的原因。这些检测还有助于确定问题出在男性、女性还是两者身上。不孕症检测和评估费用昂贵,治疗有时可能会有点不舒服。精子穿透试验、DNA 碎片和氧化应激分析是男性不孕症检测的例子,而腹腔镜检查、排卵检测、激素检测和卵巢储备检测是女性不孕症检测的例子。不孕症检测在研究机构、 医院、生育中心和诊所进行。

检测意识的增强以及生活方式的改变(不健康饮食导致男性和女性不孕不育和 妇科 疾病)是推动不孕不育检测市场增长的重要因素。此外,排卵监测技术的进步以及技术的进步也促进了市场的整体增长。此外,吸烟和烟草消费的日益流行将导致不孕不育病例增加并增加市场需求,而检测意识的增强和受 多囊卵巢综合征影响的女性人口的增加也加速了市场的整体增长并有助于市场在上述预测期内蓬勃发展。然而,高昂的安装成本和缺乏熟练的专业人员阻碍了市场的增长。

随着新产品的创新,女性对自我检测和远程监控检测的需求不断增长,预计将为市场创造盈利机会。另一方面,发展中国家不愿采用高成本检测,这可能会对市场的增长构成挑战。

本不孕不育检测市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需获取有关 Data Bridge Market Research 不孕不育检测市场的更多信息,请联系我们获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

欧洲不孕不育检测市场范围和市场规模

不孕不育检测市场根据类型、检测试剂盒、处方模式、分销渠道和最终用途进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

  • 根据类型,不孕不育检测市场分为男性不孕不育检测和女性不孕不育检测。
  • 根据检测试剂盒,不孕症检测市场细分为人类促卵泡激素 (FSH) 尿液检测试剂盒、黄体生成素 (LH) 尿液检测试剂盒、人绒毛膜促性腺激素 (HCG) 激素血液检测试剂盒等。
  • 根据处方模式,不孕不育检测市场分为处方药和非处方药(OTC)。
  • 根据分销渠道,不孕不育检测市场分为医院、药店、 网上药店以及药店和药店。
  • 根据最终用途,不孕不育检测市场分为医院和诊所、研究机构、生育中心和胚胎库。

 不孕不育检测市场国家层面分析

对不孕症检测市场进行了分析,并根据上述类型、检测试剂盒、处方模式、分销渠道和最终用途提供了市场规模洞察和趋势。

不孕不育检测市场报告涵盖的国家包括德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士和欧洲其他地区

不孕不育检测市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

不孕不育检测市场还为您提供每个国家/地区资本设备医疗支出增长、不孕不育检测市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对不孕不育检测市场的影响的详细市场分析。数据涵盖 2010 年至 2020 年的历史时期。

竞争格局和不孕不育检测市场份额分析

不孕不育检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对不孕不育检测市场的关注有关。

不孕不育检测市场的一些主要参与者包括 Metropolis Healthcare Limited India、CENTOGENE NV、Halotech DNA、宝洁、Andrology Solutions、SA Scientific、bioMérieux SA、Abbott、Quidel Corporation、Atlas Medical Uk、Babystart、SCSA Diagnostics、Gem、Merck KGaA、bioZhena Corporation、Vitrolife、Progyny Inc.、Ferring BV、FUJIFILM Irvine Scientific、Genea Limited、赛默飞世尔科技、西门子、Stryker、梅奥医学教育与研究基金会 (MFMER) 和 Dr Lal PathLabs 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Type (Female Infertility Testing and Male Infertility Testing), Test Kits (Human Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits and Others), Prescription Mode (Prescription-Based and Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies and Drug Stores), End Use (Fertility Centers, Hospitals and Clinics, Research Institutes and Cryobanks), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Rest of Europe), Industry Trends and Forecast to 2029. .
The Europe Infertility Testing Market size was valued at USD 0.00 USD Billion in 2022.
The Europe Infertility Testing Market is projected to grow at a CAGR of 7.05% during the forecast period of 2023 to 2029.
The major players operating in the market include , Metropolis Healthcare Limited India , CENTOGENE N.V , Halotech DNA , Procter & Gamble , Andrology Solutions SA , Scientific bioMérieux SA , Abbott , Quidel Corporation , Atlas Medical Uk , Babystart , SCSA Diagnostics , Gem , Merck KGaA , bioZhena Corporation , Vitrolife , Progyny , Ferring B.V. , FUJIFILM Irvine Scientific , Genea Limited , Thermo Fisher Scientific , Siemens , Stryker , Mayo Foundation for Medical Education and Research , Dr Lal PathLabs ,.